Inhibition of human recombinant soluble epoxide hydrolase assessed as cyano(6-methoxy-naphthalen-2-yl)methyl trans-[(3-phenyloxyran-2-yl)methyl] carbonate conversion to 6-methoxy-2-naphthaldehyde preincubated for 5 mins prior to substrate addition by fluorescence assay
CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,10000
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,12
C1CC(CCC1NC(=O)NC23CC4CC(C2)CC(C4)C3)OC5=CC=C(C=C5)C(=O)O,1.5
CCC(=O)N1CCC(CC1)NC(=O)NC2=CC=C(C=C2)OC(F)(F)F,3.7
CS(=O)(=O)N1CCC(CC1)NC(=O)NC2=CC=C(C=C2)OC(F)(F)F,2.9
CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,0.5
CNC(=O)C1=CC=C(C=C1)OC2CCC(CC2)NC(=O)NC34CC5CC(C3)CC(C5)C4,0.5
C1CC(CCC1NC(=O)NC2=CC(=C(C=C2)Cl)C(F)(F)F)OC3=CC=C(C=C3)C(=O)O,0.5
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)OC(F)(F)F,0.5
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC34CC5CC(C3)CC(C5)C4,0.5
CNC(=O)C1=NC=CC(=C1)OC2CCC(CC2)NC(=O)NC3=CC=C(C=C3)OC(F)(F)F,0.5
CNC(=O)C1=NC=CC(=C1)OC2CCC(CC2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,0.5
CNC(=O)C1=CC=C(C=C1)OC2CCC(CC2)NC(=O)NC3=CC=C(C=C3)OC(F)(F)F,0.5
CNC(=O)C1=NC=CC(=C1)OC2CCC(CC2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,0.5
CN(C)C(=O)C1=NC=CC(=C1)OC2CCC(CC2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,0.5
C1CC(CCC1NC(=O)NC2=CC(=C(C=C2)Cl)C(F)(F)F)OC3=CC=CC(=C3)C(=O)O,8.6
CNC(=O)C1=CC(=CC=C1)OC2CCC(CC2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,1
C1CC(CCC1NC(=O)NC2=CC=C(C=C2)OC(F)(F)F)OC3=CC=C(C=C3)C(=O)O,0.9
CNC(=O)C1=CC=C(C=C1)OC2CCC(CC2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,0.5
CNC(=O)C1=NC=C(C=C1)OC2CCC(CC2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,0.5
